IMC Chicago’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.5M Buy
804,200
+442,300
+122% +$35.4M 0.02% 497
2025
Q4
$34.5M Sell
361,900
-153,000
-30% -$15M 0.01% 619
2025
Q3
$50.3M Buy
514,900
+151,300
+42% +$15.7M 0.02% 459
2025
Q2
$39.1M Sell
363,600
-48,500
-12% -$4.91M 0.02% 467
2025
Q1
$41.6M Buy
412,100
+157,500
+62% +$15.9M 0.02% 368
2024
Q4
$22.7M Sell
254,600
-26,100
-9% -$2.3M 0.01% 559
2024
Q3
$23.5M Buy
280,700
+74,100
+36% +$5.84M 0.01% 501
2024
Q2
$15.9M Sell
206,600
-33,800
-14% -$2.47M 0.01% 604
2024
Q1
$16.5M Sell
240,400
-900
-0.4% -$57.9K 0.01% 521
2023
Q4
$13.9M Buy
241,300
+87,100
+56% +$4.65M 0.01% 561
2023
Q3
$8.14M Buy
154,200
+99,700
+183% +$5.23M 0.01% 610
2023
Q2
$2.95M Buy
54,500
+19,300
+55% +$1.01M ﹤0.01% 770
2023
Q1
$1.76M Buy
35,200
+4,800
+16% +$226K ﹤0.01% 887
2022
Q4
$1.41M Buy
30,400
+10,700
+54% +$463K ﹤0.01% 918
2022
Q3
$763K Buy
+19,700
New +$790K ﹤0.01% 1010
2021
Q1
Sell
-15,500
Closed -$557K 1046
2020
Q4
$557K Sell
15,500
-4,900
-24% -$177K ﹤0.01% 936
2020
Q3
$779K Buy
20,400
+4,500
+28% +$173K ﹤0.01% 783
2020
Q2
$558K Sell
15,900
-20,100
-56% -$724K ﹤0.01% 791
2020
Q1
$1.18M Buy
+36,000
New +$1.41M ﹤0.01% 611
2019
Q1
Sell
-8,000
Closed -$283K 655
2018
Q4
$283K Buy
+8,000
New +$290K ﹤0.01% 769

Other funds holding BSX

IMC Chicago's BSX Position: Q1 2026 in Review

IMC Chicago increased its Boston Scientific (BSX) stake by 632% in Q1 2026, buying an estimated $35.9M and bringing the position to 520,435 shares worth $32.7M. The position accounts for 0.01% of the portfolio, ranked #654.

IMC Chicago first reported a position in BSX in Q4 2018 and has held it in 9 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • IMC Chicago held 520,435 shares of Boston Scientific worth $32.7M as of Q1 2026.
  • IMC Chicago bought 449,345 Boston Scientific shares in Q1 2026, an estimated $35.9M.
  • Boston Scientific made up 0.01% of IMC Chicago's portfolio in Q1 2026, its #654 holding.
  • IMC Chicago first reported a position in Boston Scientific in Q4 2018 and has held it in 9 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.